Luying Liu Selected Research

Luying Liu Research Topics

Disease

12	Rectal Neoplasms (Rectal Cancer) 10/2023 - 09/2011
8	Neoplasms (Cancer) 01/2022 - 09/2011
6	Inflammation (Inflammations) 01/2023 - 01/2019
4	Thrombosis (Thrombus) 01/2023 - 04/2019
4	Adenocarcinoma 10/2021 - 01/2015
3	Pathologic Complete Response 12/2020 - 09/2011
3	Carcinogenesis 01/2019 - 11/2007
2	Atherosclerosis 01/2023 - 01/2020
2	Infections 01/2022 - 11/2017
2	Stomach Neoplasms (Stomach Cancer) 10/2021 - 11/2007
2	Hyperplasia 05/2020 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 12/2014
2	Lymphoma (Lymphomas) 02/2017 - 01/2016
1	Hyperlipidemias (Hyperlipidemia) 01/2023
1	Intervertebral Disc Degeneration 01/2022
1	Corneal Injuries 01/2022
1	Osteoarthritis 01/2022
1	Rheumatoid Arthritis 01/2022
1	Cartilage Diseases (Cartilage Disease) 01/2022
1	Pain (Aches) 01/2022
1	Osteoporosis 01/2022
1	Hearing Loss (Hearing Impairment) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2019
1	Leukopenia 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 08/2018
1	Liver Failure 02/2017
1	Rare Diseases (Rare Disease) 02/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 04/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Liver Neoplasms (Liver Cancer) 01/2012
1	Pathologic Processes 11/2007

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2015
2	baicalinIBA 01/2023 - 01/2022
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2020 - 03/2015
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2011
2	fibrin fragment D (D-dimer)IBA 01/2015 - 12/2014
1	LipidsIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	AntioxidantsIBA 04/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022
1	B7-H1 AntigenIBA 02/2022
1	TOR Serine-Threonine KinasesIBA 02/2022
1	GenisteinIBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	IsoflavonesIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2020
1	Uridine Diphosphate (UDP)IBA 12/2020
1	Capecitabine (Xeloda)FDA Link 12/2020
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 12/2020
1	CopperIBA 05/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	AnticoagulantsIBA 01/2020
1	PolymersIBA 01/2020
1	CrizotinibIBA 08/2018
1	Type IV Secretion SystemsIBA 11/2017
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	GlobulinsIBA 01/2017
1	Rituximab (Mabthera)FDA Link 01/2016
1	Tumor Biomarkers (Tumor Markers)IBA 04/2015
1	Glycoproteins (Glycoprotein)IBA 04/2015
1	CA-72-4 antigenIBA 04/2015
1	Fluorouracil (Carac)FDA LinkGeneric 03/2015
1	Leucovorin (Folinic Acid)FDA Link 03/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Bevacizumab (Avastin)FDA Link 12/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012
1	Annexin A5IBA 01/2012
1	QuercetinIBA 01/2012
1	Fibrinogen (Factor I)FDA Link 09/2011
1	Connective Tissue Growth FactorIBA 11/2007
1	Vascular Endothelial Growth Factor CIBA 11/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2007

Therapy/Procedure

8	Neoadjuvant Therapy 10/2023 - 03/2015
6	Chemoradiotherapy 10/2021 - 09/2011
6	Drug Therapy (Chemotherapy) 10/2021 - 01/2015
4	Radiotherapy 01/2016 - 08/2012
3	Stents 01/2023 - 04/2019
3	Therapeutics 10/2021 - 01/2015
2	Adjuvant Chemotherapy 01/2020 - 08/2018
1	Contact Lenses 01/2022
1	Adjuvant Radiotherapy 10/2021
1	Gastrectomy 10/2021
1	Lymph Node Excision (Lymph Node Dissection) 10/2021
1	Drug-Eluting Stents 01/2020
1	Adjuvant Chemoradiotherapy 01/2019
1	Segmental Mastectomy (Lumpectomy) 02/2017